Endometriosis Typology and Ovarian Cancer Risk.

IF 63.1 1区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Mollie E Barnard, Leslie V Farland, Bin Yan, Jing Wang, Britton Trabert, Jennifer A Doherty, Huong D Meeks, Myke Madsen, Emily Guinto, Lindsay J Collin, Kathryn A Maurer, Jessica M Page, Amber C Kiser, Michael W Varner, Kristina Allen-Brady, Anna Z Pollack, Kurt R Peterson, C Matthew Peterson, Karen C Schliep
{"title":"Endometriosis Typology and Ovarian Cancer Risk.","authors":"Mollie E Barnard, Leslie V Farland, Bin Yan, Jing Wang, Britton Trabert, Jennifer A Doherty, Huong D Meeks, Myke Madsen, Emily Guinto, Lindsay J Collin, Kathryn A Maurer, Jessica M Page, Amber C Kiser, Michael W Varner, Kristina Allen-Brady, Anna Z Pollack, Kurt R Peterson, C Matthew Peterson, Karen C Schliep","doi":"10.1001/jama.2024.9210","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.</p><p><strong>Objective: </strong>To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.</p><p><strong>Design, setting, and participants: </strong>Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.</p><p><strong>Exposures: </strong>Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.</p><p><strong>Main outcomes and measures: </strong>Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.</p><p><strong>Results: </strong>In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).</p><p><strong>Conclusions and relevance: </strong>Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.</p>","PeriodicalId":54909,"journal":{"name":"Jama-Journal of the American Medical Association","volume":" ","pages":"482-489"},"PeriodicalIF":63.1000,"publicationDate":"2024-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11255975/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jama-Journal of the American Medical Association","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jama.2024.9210","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

Objective: To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype.

Design, setting, and participants: Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis.

Exposures: Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other.

Main outcomes and measures: Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

Results: In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, -0.01 to 4.85]).

Conclusions and relevance: Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.

子宫内膜异位症类型与卵巢癌风险。
重要性:子宫内膜异位症与卵巢癌风险的增加有关;然而,子宫内膜异位症亚型与卵巢癌组织类型之间的关系尚未得到很好的描述:评估子宫内膜异位症亚型与卵巢癌发病率的关系,包括总体关系和组织型关系:基于人口的队列研究,使用犹他州人口数据库的数据。该队列由 78 893 名患有子宫内膜异位症的妇女与未患有子宫内膜异位症的妇女按 1:5 的比例配对而成:子宫内膜异位症病例通过电子健康记录确定,分为浅表性子宫内膜异位症、卵巢子宫内膜异位症、深部浸润性子宫内膜异位症或其他:将患有各种类型子宫内膜异位症的女性与未患子宫内膜异位症的女性进行比较,估计每万名女性患卵巢癌、I型卵巢癌和II型卵巢癌的调整后危险比(aHRs)、调整后风险差异(aRDs)和95%CIs。模型考虑了社会人口因素、生育史和以往的妇科手术:在这个以犹他州为基地的队列中,首次确诊子宫内膜异位症的平均(标清)年龄为 36(10)岁。其中有 597 名妇女患有卵巢癌。与无子宫内膜异位症的妇女相比,患有子宫内膜异位症的妇女患卵巢癌的风险更高(aHR,4.20 [95% CI,3.59-4.91];aRD,9.90 [95% CI,7.22-12.57]),I型卵巢癌的风险尤其高(aHR,7.48 [95% CI,5.80-9.65];aRD,7.53 [95% CI,5.46-9.61])。在所有卵巢癌中,患有深度浸润性子宫内膜异位症和/或卵巢子宫内膜异位症的妇女患卵巢癌的风险最高(aHR,9.66 [95% CI,7.77-12.00];aRD,26.71 [95% CI,20.01-33.41])。41])、I型卵巢癌(aHR,18.96 [95% CI,13.78-26.08];aRD,19.57 [95% CI,13.80-25.35])和II型卵巢癌(aHR,3.72 [95% CI,2.31-5.98];aRD,2.42 [95% CI,-0.01-4.85]):患有卵巢子宫内膜异位症和/或深部浸润性子宫内膜异位症的妇女患卵巢癌的风险明显增加。这一人群可能会从有关卵巢癌风险和预防的咨询中受益,并可能成为有针对性的筛查和预防研究的重要人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
48.20
自引率
0.90%
发文量
1569
审稿时长
2 months
期刊介绍: JAMA (Journal of the American Medical Association) is an international peer-reviewed general medical journal. It has been published continuously since 1883. JAMA is a member of the JAMA Network, which is a consortium of peer-reviewed general medical and specialty publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信